Global Neurological Biomarkers Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
A biomarker, or biological marker is a measurable indicator of some biological state or condition. Biomarkers are often measured and evaluated to examine normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Biomarkers are used in many scientific fields. Neurology disorders are affecting major percentage of the global population and it is considered a major cause of disability around the globe. The prevalence of neurological disorders is growing at a very high pace, in which biomarkers are expected play a vital role in better understanding of the disease and development of personalized medicine specific to the patient.
Scope of the Report:
This report studies the Neurological Biomarkers market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neurological Biomarkers market by product type and applications/end industries.
North Amercian was the leading market in 2017, and is expected to continue this trend throughout the forecast period. This is attributed to rise in expenditure on the management of Parkinson’s disease in the country. As of 2017, North Amercian had a population of 326,506,644 individuals, and about 60,000 individuals are diagnosed with Parkinson’s diseases every year. Thus, significant prevalence of this disease among the North Amercian population drives the growth of the market. However, China is projected to emerge as a lucrative market in future, due to the higher prevalence of Parkinson’s disease observed in males in 2017.
The global Neurological Biomarkers market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neurological Biomarkers.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Scope of the Report:
This report studies the Neurological Biomarkers market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neurological Biomarkers market by product type and applications/end industries.
North Amercian was the leading market in 2017, and is expected to continue this trend throughout the forecast period. This is attributed to rise in expenditure on the management of Parkinson’s disease in the country. As of 2017, North Amercian had a population of 326,506,644 individuals, and about 60,000 individuals are diagnosed with Parkinson’s diseases every year. Thus, significant prevalence of this disease among the North Amercian population drives the growth of the market. However, China is projected to emerge as a lucrative market in future, due to the higher prevalence of Parkinson’s disease observed in males in 2017.
The global Neurological Biomarkers market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neurological Biomarkers.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Quanterix
- Myriad RBM
- QIAGEN
- ADx NeuroSciences
- Merck
- Euroimmun
- Thermo Fisher
- BioCrypton
- ACOBIOM
- Banyan Biomarkers
- Olink Biosciences
- BioAgilytix
- Abbott Laboratories
- Proteome Sciences
- Athena Diagnostics
- Psynova Neurotech
- Bio-Rad Laboratories
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Genomics Biomarker
- Proteomics Biomarker
- Metabolomics Biomarkers
- Imaging Biomarkers
- Others
- Research Organizations, Pharma & Biotech Companies
- Clinical Diagnostics
1 NEUROLOGICAL BIOMARKERS MARKET OVERVIEW
1.1 Product Overview and Scope of Neurological Biomarkers
1.2 Classification of Neurological Biomarkers by Types
1.2.1 Global Neurological Biomarkers Revenue Comparison by Types (2017-2023)
1.2.2 Global Neurological Biomarkers Revenue Market Share by Types in 2017
1.2.3 Genomics Biomarker
1.2.4 Proteomics Biomarker
1.2.5 Metabolomics Biomarkers
1.2.6 Imaging Biomarkers
1.2.7 Others
1.3 Global Neurological Biomarkers Market by Application
1.3.1 Global Neurological Biomarkers Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Research Organizations, Pharma & Biotech Companies
1.3.3 Clinical Diagnostics
1.4 Global Neurological Biomarkers Market by Regions
1.4.1 Global Neurological Biomarkers Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Neurological Biomarkers Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Neurological Biomarkers Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neurological Biomarkers Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Neurological Biomarkers Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neurological Biomarkers Status and Prospect (2013-2023)
1.5 Global Market Size of Neurological Biomarkers (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Quanterix
2.1.1 Business Overview
2.1.2 Neurological Biomarkers Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Quanterix Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.2 Myriad RBM
2.2.1 Business Overview
2.2.2 Neurological Biomarkers Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Myriad RBM Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.3 QIAGEN
2.3.1 Business Overview
2.3.2 Neurological Biomarkers Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 QIAGEN Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.4 ADx NeuroSciences
2.4.1 Business Overview
2.4.2 Neurological Biomarkers Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 ADx NeuroSciences Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.5 Merck
2.5.1 Business Overview
2.5.2 Neurological Biomarkers Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.6 Euroimmun
2.6.1 Business Overview
2.6.2 Neurological Biomarkers Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Euroimmun Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.7 Thermo Fisher
2.7.1 Business Overview
2.7.2 Neurological Biomarkers Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Thermo Fisher Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.8 BioCrypton
2.8.1 Business Overview
2.8.2 Neurological Biomarkers Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 BioCrypton Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.9 ACOBIOM
2.9.1 Business Overview
2.9.2 Neurological Biomarkers Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 ACOBIOM Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.10 Banyan Biomarkers
2.10.1 Business Overview
2.10.2 Neurological Biomarkers Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Banyan Biomarkers Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.11 Olink Biosciences
2.11.1 Business Overview
2.11.2 Neurological Biomarkers Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Olink Biosciences Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.12 BioAgilytix
2.12.1 Business Overview
2.12.2 Neurological Biomarkers Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 BioAgilytix Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.13 Abbott Laboratories
2.13.1 Business Overview
2.13.2 Neurological Biomarkers Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Abbott Laboratories Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.14 Proteome Sciences
2.14.1 Business Overview
2.14.2 Neurological Biomarkers Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Proteome Sciences Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.15 Athena Diagnostics
2.15.1 Business Overview
2.15.2 Neurological Biomarkers Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Athena Diagnostics Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.16 Psynova Neurotech
2.16.1 Business Overview
2.16.2 Neurological Biomarkers Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Psynova Neurotech Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.17 Bio-Rad Laboratories
2.17.1 Business Overview
2.17.2 Neurological Biomarkers Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Bio-Rad Laboratories Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL NEUROLOGICAL BIOMARKERS MARKET COMPETITION, BY PLAYERS
3.1 Global Neurological Biomarkers Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Neurological Biomarkers Players Market Share
3.2.2 Top 10 Neurological Biomarkers Players Market Share
3.3 Market Competition Trend
4 GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE BY REGIONS
4.1 Global Neurological Biomarkers Revenue and Market Share by Regions
4.2 North America Neurological Biomarkers Revenue and Growth Rate (2013-2018)
4.3 Europe Neurological Biomarkers Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Neurological Biomarkers Revenue and Growth Rate (2013-2018)
4.5 South America Neurological Biomarkers Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Neurological Biomarkers Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA NEUROLOGICAL BIOMARKERS REVENUE BY COUNTRIES
5.1 North America Neurological Biomarkers Revenue by Countries (2013-2018)
5.2 USA Neurological Biomarkers Revenue and Growth Rate (2013-2018)
5.3 Canada Neurological Biomarkers Revenue and Growth Rate (2013-2018)
5.4 Mexico Neurological Biomarkers Revenue and Growth Rate (2013-2018)
6 EUROPE NEUROLOGICAL BIOMARKERS REVENUE BY COUNTRIES
6.1 Europe Neurological Biomarkers Revenue by Countries (2013-2018)
6.2 Germany Neurological Biomarkers Revenue and Growth Rate (2013-2018)
6.3 UK Neurological Biomarkers Revenue and Growth Rate (2013-2018)
6.4 France Neurological Biomarkers Revenue and Growth Rate (2013-2018)
6.5 Russia Neurological Biomarkers Revenue and Growth Rate (2013-2018)
6.6 Italy Neurological Biomarkers Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC NEUROLOGICAL BIOMARKERS REVENUE BY COUNTRIES
7.1 Asia-Pacific Neurological Biomarkers Revenue by Countries (2013-2018)
7.2 China Neurological Biomarkers Revenue and Growth Rate (2013-2018)
7.3 Japan Neurological Biomarkers Revenue and Growth Rate (2013-2018)
7.4 Korea Neurological Biomarkers Revenue and Growth Rate (2013-2018)
7.5 India Neurological Biomarkers Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Neurological Biomarkers Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA NEUROLOGICAL BIOMARKERS REVENUE BY COUNTRIES
8.1 South America Neurological Biomarkers Revenue by Countries (2013-2018)
8.2 Brazil Neurological Biomarkers Revenue and Growth Rate (2013-2018)
8.3 Argentina Neurological Biomarkers Revenue and Growth Rate (2013-2018)
8.4 Colombia Neurological Biomarkers Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE NEUROLOGICAL BIOMARKERS BY COUNTRIES
9.1 Middle East and Africa Neurological Biomarkers Revenue by Countries (2013-2018)
9.2 Saudi Arabia Neurological Biomarkers Revenue and Growth Rate (2013-2018)
9.3 UAE Neurological Biomarkers Revenue and Growth Rate (2013-2018)
9.4 Egypt Neurological Biomarkers Revenue and Growth Rate (2013-2018)
9.5 Nigeria Neurological Biomarkers Revenue and Growth Rate (2013-2018)
9.6 South Africa Neurological Biomarkers Revenue and Growth Rate (2013-2018)
10 GLOBAL NEUROLOGICAL BIOMARKERS MARKET SEGMENT BY TYPE
10.1 Global Neurological Biomarkers Revenue and Market Share by Type (2013-2018)
10.2 Global Neurological Biomarkers Market Forecast by Type (2018-2023)
10.3 Genomics Biomarker Revenue Growth Rate (2013-2023)
10.4 Proteomics Biomarker Revenue Growth Rate (2013-2023)
10.5 Metabolomics Biomarkers Revenue Growth Rate (2013-2023)
10.6 Imaging Biomarkers Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)
11 GLOBAL NEUROLOGICAL BIOMARKERS MARKET SEGMENT BY APPLICATION
11.1 Global Neurological Biomarkers Revenue Market Share by Application (2013-2018)
11.2 Neurological Biomarkers Market Forecast by Application (2018-2023)
11.3 Research Organizations, Pharma & Biotech Companies Revenue Growth (2013-2018)
11.4 Clinical Diagnostics Revenue Growth (2013-2018)
12 GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE FORECAST (2018-2023)
12.1 Global Neurological Biomarkers Market Size Forecast (2018-2023)
12.2 Global Neurological Biomarkers Market Forecast by Regions (2018-2023)
12.3 North America Neurological Biomarkers Revenue Market Forecast (2018-2023)
12.4 Europe Neurological Biomarkers Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Neurological Biomarkers Revenue Market Forecast (2018-2023)
12.6 South America Neurological Biomarkers Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Neurological Biomarkers Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Neurological Biomarkers
1.2 Classification of Neurological Biomarkers by Types
1.2.1 Global Neurological Biomarkers Revenue Comparison by Types (2017-2023)
1.2.2 Global Neurological Biomarkers Revenue Market Share by Types in 2017
1.2.3 Genomics Biomarker
1.2.4 Proteomics Biomarker
1.2.5 Metabolomics Biomarkers
1.2.6 Imaging Biomarkers
1.2.7 Others
1.3 Global Neurological Biomarkers Market by Application
1.3.1 Global Neurological Biomarkers Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Research Organizations, Pharma & Biotech Companies
1.3.3 Clinical Diagnostics
1.4 Global Neurological Biomarkers Market by Regions
1.4.1 Global Neurological Biomarkers Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Neurological Biomarkers Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Neurological Biomarkers Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neurological Biomarkers Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Neurological Biomarkers Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neurological Biomarkers Status and Prospect (2013-2023)
1.5 Global Market Size of Neurological Biomarkers (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Quanterix
2.1.1 Business Overview
2.1.2 Neurological Biomarkers Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Quanterix Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.2 Myriad RBM
2.2.1 Business Overview
2.2.2 Neurological Biomarkers Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Myriad RBM Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.3 QIAGEN
2.3.1 Business Overview
2.3.2 Neurological Biomarkers Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 QIAGEN Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.4 ADx NeuroSciences
2.4.1 Business Overview
2.4.2 Neurological Biomarkers Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 ADx NeuroSciences Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.5 Merck
2.5.1 Business Overview
2.5.2 Neurological Biomarkers Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.6 Euroimmun
2.6.1 Business Overview
2.6.2 Neurological Biomarkers Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Euroimmun Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.7 Thermo Fisher
2.7.1 Business Overview
2.7.2 Neurological Biomarkers Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Thermo Fisher Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.8 BioCrypton
2.8.1 Business Overview
2.8.2 Neurological Biomarkers Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 BioCrypton Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.9 ACOBIOM
2.9.1 Business Overview
2.9.2 Neurological Biomarkers Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 ACOBIOM Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.10 Banyan Biomarkers
2.10.1 Business Overview
2.10.2 Neurological Biomarkers Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Banyan Biomarkers Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.11 Olink Biosciences
2.11.1 Business Overview
2.11.2 Neurological Biomarkers Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Olink Biosciences Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.12 BioAgilytix
2.12.1 Business Overview
2.12.2 Neurological Biomarkers Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 BioAgilytix Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.13 Abbott Laboratories
2.13.1 Business Overview
2.13.2 Neurological Biomarkers Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Abbott Laboratories Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.14 Proteome Sciences
2.14.1 Business Overview
2.14.2 Neurological Biomarkers Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Proteome Sciences Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.15 Athena Diagnostics
2.15.1 Business Overview
2.15.2 Neurological Biomarkers Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Athena Diagnostics Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.16 Psynova Neurotech
2.16.1 Business Overview
2.16.2 Neurological Biomarkers Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Psynova Neurotech Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.17 Bio-Rad Laboratories
2.17.1 Business Overview
2.17.2 Neurological Biomarkers Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Bio-Rad Laboratories Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL NEUROLOGICAL BIOMARKERS MARKET COMPETITION, BY PLAYERS
3.1 Global Neurological Biomarkers Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Neurological Biomarkers Players Market Share
3.2.2 Top 10 Neurological Biomarkers Players Market Share
3.3 Market Competition Trend
4 GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE BY REGIONS
4.1 Global Neurological Biomarkers Revenue and Market Share by Regions
4.2 North America Neurological Biomarkers Revenue and Growth Rate (2013-2018)
4.3 Europe Neurological Biomarkers Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Neurological Biomarkers Revenue and Growth Rate (2013-2018)
4.5 South America Neurological Biomarkers Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Neurological Biomarkers Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA NEUROLOGICAL BIOMARKERS REVENUE BY COUNTRIES
5.1 North America Neurological Biomarkers Revenue by Countries (2013-2018)
5.2 USA Neurological Biomarkers Revenue and Growth Rate (2013-2018)
5.3 Canada Neurological Biomarkers Revenue and Growth Rate (2013-2018)
5.4 Mexico Neurological Biomarkers Revenue and Growth Rate (2013-2018)
6 EUROPE NEUROLOGICAL BIOMARKERS REVENUE BY COUNTRIES
6.1 Europe Neurological Biomarkers Revenue by Countries (2013-2018)
6.2 Germany Neurological Biomarkers Revenue and Growth Rate (2013-2018)
6.3 UK Neurological Biomarkers Revenue and Growth Rate (2013-2018)
6.4 France Neurological Biomarkers Revenue and Growth Rate (2013-2018)
6.5 Russia Neurological Biomarkers Revenue and Growth Rate (2013-2018)
6.6 Italy Neurological Biomarkers Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC NEUROLOGICAL BIOMARKERS REVENUE BY COUNTRIES
7.1 Asia-Pacific Neurological Biomarkers Revenue by Countries (2013-2018)
7.2 China Neurological Biomarkers Revenue and Growth Rate (2013-2018)
7.3 Japan Neurological Biomarkers Revenue and Growth Rate (2013-2018)
7.4 Korea Neurological Biomarkers Revenue and Growth Rate (2013-2018)
7.5 India Neurological Biomarkers Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Neurological Biomarkers Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA NEUROLOGICAL BIOMARKERS REVENUE BY COUNTRIES
8.1 South America Neurological Biomarkers Revenue by Countries (2013-2018)
8.2 Brazil Neurological Biomarkers Revenue and Growth Rate (2013-2018)
8.3 Argentina Neurological Biomarkers Revenue and Growth Rate (2013-2018)
8.4 Colombia Neurological Biomarkers Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE NEUROLOGICAL BIOMARKERS BY COUNTRIES
9.1 Middle East and Africa Neurological Biomarkers Revenue by Countries (2013-2018)
9.2 Saudi Arabia Neurological Biomarkers Revenue and Growth Rate (2013-2018)
9.3 UAE Neurological Biomarkers Revenue and Growth Rate (2013-2018)
9.4 Egypt Neurological Biomarkers Revenue and Growth Rate (2013-2018)
9.5 Nigeria Neurological Biomarkers Revenue and Growth Rate (2013-2018)
9.6 South Africa Neurological Biomarkers Revenue and Growth Rate (2013-2018)
10 GLOBAL NEUROLOGICAL BIOMARKERS MARKET SEGMENT BY TYPE
10.1 Global Neurological Biomarkers Revenue and Market Share by Type (2013-2018)
10.2 Global Neurological Biomarkers Market Forecast by Type (2018-2023)
10.3 Genomics Biomarker Revenue Growth Rate (2013-2023)
10.4 Proteomics Biomarker Revenue Growth Rate (2013-2023)
10.5 Metabolomics Biomarkers Revenue Growth Rate (2013-2023)
10.6 Imaging Biomarkers Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)
11 GLOBAL NEUROLOGICAL BIOMARKERS MARKET SEGMENT BY APPLICATION
11.1 Global Neurological Biomarkers Revenue Market Share by Application (2013-2018)
11.2 Neurological Biomarkers Market Forecast by Application (2018-2023)
11.3 Research Organizations, Pharma & Biotech Companies Revenue Growth (2013-2018)
11.4 Clinical Diagnostics Revenue Growth (2013-2018)
12 GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE FORECAST (2018-2023)
12.1 Global Neurological Biomarkers Market Size Forecast (2018-2023)
12.2 Global Neurological Biomarkers Market Forecast by Regions (2018-2023)
12.3 North America Neurological Biomarkers Revenue Market Forecast (2018-2023)
12.4 Europe Neurological Biomarkers Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Neurological Biomarkers Revenue Market Forecast (2018-2023)
12.6 South America Neurological Biomarkers Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Neurological Biomarkers Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Neurological Biomarkers Picture
Table Product Specifications of Neurological Biomarkers
Table Global Neurological Biomarkers and Revenue (Million USD) Market Split by Product Type
Figure Global Neurological Biomarkers Revenue Market Share by Types in 2017
Figure Genomics Biomarker Picture
Figure Proteomics Biomarker Picture
Figure Metabolomics Biomarkers Picture
Figure Imaging Biomarkers Picture
Figure Others Picture
Table Global Neurological Biomarkers Revenue (Million USD) by Application (2013-2023)
Figure Neurological Biomarkers Revenue Market Share by Applications in 2017
Figure Research Organizations, Pharma & Biotech Companies Picture
Figure Clinical Diagnostics Picture
Table Global Market Neurological Biomarkers Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Neurological Biomarkers Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Neurological Biomarkers Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Neurological Biomarkers Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Neurological Biomarkers Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Neurological Biomarkers Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate (2013-2023)
Table Quanterix Basic Information, Manufacturing Base and Competitors
Table Quanterix Neurological Biomarkers Type and Applications
Table Quanterix Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Myriad RBM Basic Information, Manufacturing Base and Competitors
Table Myriad RBM Neurological Biomarkers Type and Applications
Table Myriad RBM Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table QIAGEN Basic Information, Manufacturing Base and Competitors
Table QIAGEN Neurological Biomarkers Type and Applications
Table QIAGEN Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table ADx NeuroSciences Basic Information, Manufacturing Base and Competitors
Table ADx NeuroSciences Neurological Biomarkers Type and Applications
Table ADx NeuroSciences Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Neurological Biomarkers Type and Applications
Table Merck Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Euroimmun Basic Information, Manufacturing Base and Competitors
Table Euroimmun Neurological Biomarkers Type and Applications
Table Euroimmun Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Neurological Biomarkers Type and Applications
Table Thermo Fisher Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table BioCrypton Basic Information, Manufacturing Base and Competitors
Table BioCrypton Neurological Biomarkers Type and Applications
Table BioCrypton Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table ACOBIOM Basic Information, Manufacturing Base and Competitors
Table ACOBIOM Neurological Biomarkers Type and Applications
Table ACOBIOM Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Banyan Biomarkers Basic Information, Manufacturing Base and Competitors
Table Banyan Biomarkers Neurological Biomarkers Type and Applications
Table Banyan Biomarkers Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Olink Biosciences Basic Information, Manufacturing Base and Competitors
Table Olink Biosciences Neurological Biomarkers Type and Applications
Table Olink Biosciences Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table BioAgilytix Basic Information, Manufacturing Base and Competitors
Table BioAgilytix Neurological Biomarkers Type and Applications
Table BioAgilytix Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Neurological Biomarkers Type and Applications
Table Abbott Laboratories Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Proteome Sciences Basic Information, Manufacturing Base and Competitors
Table Proteome Sciences Neurological Biomarkers Type and Applications
Table Proteome Sciences Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Athena Diagnostics Basic Information, Manufacturing Base and Competitors
Table Athena Diagnostics Neurological Biomarkers Type and Applications
Table Athena Diagnostics Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Psynova Neurotech Basic Information, Manufacturing Base and Competitors
Table Psynova Neurotech Neurological Biomarkers Type and Applications
Table Psynova Neurotech Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table Bio-Rad Laboratories Neurological Biomarkers Type and Applications
Table Bio-Rad Laboratories Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Global Neurological Biomarkers Revenue (Million USD) by Players (2013-2018)
Table Global Neurological Biomarkers Revenue Share by Players (2013-2018)
Figure Global Neurological Biomarkers Revenue Share by Players in 2016
Figure Global Neurological Biomarkers Revenue Share by Players in 2017
Figure Global Top 5 Players Neurological Biomarkers Revenue Market Share in 2017
Figure Global Top 10 Players Neurological Biomarkers Revenue Market Share in 2017
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Neurological Biomarkers Revenue (Million USD) by Regions (2013-2018)
Table Global Neurological Biomarkers Revenue Market Share by Regions (2013-2018)
Figure Global Neurological Biomarkers Revenue Market Share by Regions (2013-2018)
Figure Global Neurological Biomarkers Revenue Market Share by Regions in 2017
Figure North America Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Europe Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure South America Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Table North America Neurological Biomarkers Revenue by Countries (2013-2018)
Table North America Neurological Biomarkers Revenue Market Share by Countries (2013-2018)
Figure North America Neurological Biomarkers Revenue Market Share by Countries (2013-2018)
Figure North America Neurological Biomarkers Revenue Market Share by Countries in 2017
Figure USA Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Canada Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Mexico Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Table Europe Neurological Biomarkers Revenue (Million USD) by Countries (2013-2018)
Figure Europe Neurological Biomarkers Revenue Market Share by Countries (2013-2018)
Figure Europe Neurological Biomarkers Revenue Market Share by Countries in 2017
Figure Germany Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure UK Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure France Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Russia Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Italy Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Neurological Biomarkers Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Countries in 2017
Figure China Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Japan Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Korea Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure India Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Table South America Neurological Biomarkers Revenue by Countries (2013-2018)
Table South America Neurological Biomarkers Revenue Market Share by Countries (2013-2018)
Figure South America Neurological Biomarkers Revenue Market Share by Countries (2013-2018)
Figure South America Neurological Biomarkers Revenue Market Share by Countries in 2017
Figure Brazil Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Argentina Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Colombia Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Neurological Biomarkers Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries in 2017
Figure Saudi Arabia Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure UAE Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Egypt Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Nigeria Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure South Africa Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Table Global Neurological Biomarkers Revenue (Million USD) by Type (2013-2018)
Table Global Neurological Biomarkers Revenue Share by Type (2013-2018)
Figure Global Neurological Biomarkers Revenue Share by Type (2013-2018)
Figure Global Neurological Biomarkers Revenue Share by Type in 2017
Table Global Neurological Biomarkers Revenue Forecast by Type (2018-2023)
Figure Global Neurological Biomarkers Market Share Forecast by Type (2018-2023)
Figure Global Genomics Biomarker Revenue Growth Rate (2013-2018)
Figure Global Proteomics Biomarker Revenue Growth Rate (2013-2018)
Figure Global Metabolomics Biomarkers Revenue Growth Rate (2013-2018)
Figure Global Imaging Biomarkers Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Neurological Biomarkers Revenue by Application (2013-2018)
Table Global Neurological Biomarkers Revenue Share by Application (2013-2018)
Figure Global Neurological Biomarkers Revenue Share by Application (2013-2018)
Figure Global Neurological Biomarkers Revenue Share by Application in 2017
Table Global Neurological Biomarkers Revenue Forecast by Application (2018-2023)
Figure Global Neurological Biomarkers Market Share Forecast by Application (2018-2023)
Figure Global Research Organizations, Pharma & Biotech Companies Revenue Growth Rate (2013-2018)
Figure Global Clinical Diagnostics Revenue Growth Rate (2013-2018)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Neurological Biomarkers Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Neurological Biomarkers Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Neurological Biomarkers Revenue Market Forecast (2018-2023)
Figure Europe Neurological Biomarkers Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Forecast (2018-2023)
Figure South America Neurological Biomarkers Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Neurological Biomarkers Revenue Market Forecast (2018-2023)
Figure Neurological Biomarkers Picture
Table Product Specifications of Neurological Biomarkers
Table Global Neurological Biomarkers and Revenue (Million USD) Market Split by Product Type
Figure Global Neurological Biomarkers Revenue Market Share by Types in 2017
Figure Genomics Biomarker Picture
Figure Proteomics Biomarker Picture
Figure Metabolomics Biomarkers Picture
Figure Imaging Biomarkers Picture
Figure Others Picture
Table Global Neurological Biomarkers Revenue (Million USD) by Application (2013-2023)
Figure Neurological Biomarkers Revenue Market Share by Applications in 2017
Figure Research Organizations, Pharma & Biotech Companies Picture
Figure Clinical Diagnostics Picture
Table Global Market Neurological Biomarkers Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Neurological Biomarkers Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Neurological Biomarkers Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Neurological Biomarkers Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Neurological Biomarkers Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Neurological Biomarkers Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate (2013-2023)
Table Quanterix Basic Information, Manufacturing Base and Competitors
Table Quanterix Neurological Biomarkers Type and Applications
Table Quanterix Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Myriad RBM Basic Information, Manufacturing Base and Competitors
Table Myriad RBM Neurological Biomarkers Type and Applications
Table Myriad RBM Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table QIAGEN Basic Information, Manufacturing Base and Competitors
Table QIAGEN Neurological Biomarkers Type and Applications
Table QIAGEN Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table ADx NeuroSciences Basic Information, Manufacturing Base and Competitors
Table ADx NeuroSciences Neurological Biomarkers Type and Applications
Table ADx NeuroSciences Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Neurological Biomarkers Type and Applications
Table Merck Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Euroimmun Basic Information, Manufacturing Base and Competitors
Table Euroimmun Neurological Biomarkers Type and Applications
Table Euroimmun Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Neurological Biomarkers Type and Applications
Table Thermo Fisher Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table BioCrypton Basic Information, Manufacturing Base and Competitors
Table BioCrypton Neurological Biomarkers Type and Applications
Table BioCrypton Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table ACOBIOM Basic Information, Manufacturing Base and Competitors
Table ACOBIOM Neurological Biomarkers Type and Applications
Table ACOBIOM Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Banyan Biomarkers Basic Information, Manufacturing Base and Competitors
Table Banyan Biomarkers Neurological Biomarkers Type and Applications
Table Banyan Biomarkers Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Olink Biosciences Basic Information, Manufacturing Base and Competitors
Table Olink Biosciences Neurological Biomarkers Type and Applications
Table Olink Biosciences Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table BioAgilytix Basic Information, Manufacturing Base and Competitors
Table BioAgilytix Neurological Biomarkers Type and Applications
Table BioAgilytix Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Neurological Biomarkers Type and Applications
Table Abbott Laboratories Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Proteome Sciences Basic Information, Manufacturing Base and Competitors
Table Proteome Sciences Neurological Biomarkers Type and Applications
Table Proteome Sciences Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Athena Diagnostics Basic Information, Manufacturing Base and Competitors
Table Athena Diagnostics Neurological Biomarkers Type and Applications
Table Athena Diagnostics Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Psynova Neurotech Basic Information, Manufacturing Base and Competitors
Table Psynova Neurotech Neurological Biomarkers Type and Applications
Table Psynova Neurotech Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table Bio-Rad Laboratories Neurological Biomarkers Type and Applications
Table Bio-Rad Laboratories Neurological Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Global Neurological Biomarkers Revenue (Million USD) by Players (2013-2018)
Table Global Neurological Biomarkers Revenue Share by Players (2013-2018)
Figure Global Neurological Biomarkers Revenue Share by Players in 2016
Figure Global Neurological Biomarkers Revenue Share by Players in 2017
Figure Global Top 5 Players Neurological Biomarkers Revenue Market Share in 2017
Figure Global Top 10 Players Neurological Biomarkers Revenue Market Share in 2017
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Neurological Biomarkers Revenue (Million USD) by Regions (2013-2018)
Table Global Neurological Biomarkers Revenue Market Share by Regions (2013-2018)
Figure Global Neurological Biomarkers Revenue Market Share by Regions (2013-2018)
Figure Global Neurological Biomarkers Revenue Market Share by Regions in 2017
Figure North America Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Europe Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure South America Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Table North America Neurological Biomarkers Revenue by Countries (2013-2018)
Table North America Neurological Biomarkers Revenue Market Share by Countries (2013-2018)
Figure North America Neurological Biomarkers Revenue Market Share by Countries (2013-2018)
Figure North America Neurological Biomarkers Revenue Market Share by Countries in 2017
Figure USA Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Canada Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Mexico Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Table Europe Neurological Biomarkers Revenue (Million USD) by Countries (2013-2018)
Figure Europe Neurological Biomarkers Revenue Market Share by Countries (2013-2018)
Figure Europe Neurological Biomarkers Revenue Market Share by Countries in 2017
Figure Germany Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure UK Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure France Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Russia Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Italy Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Neurological Biomarkers Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Countries in 2017
Figure China Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Japan Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Korea Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure India Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Table South America Neurological Biomarkers Revenue by Countries (2013-2018)
Table South America Neurological Biomarkers Revenue Market Share by Countries (2013-2018)
Figure South America Neurological Biomarkers Revenue Market Share by Countries (2013-2018)
Figure South America Neurological Biomarkers Revenue Market Share by Countries in 2017
Figure Brazil Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Argentina Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Colombia Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Neurological Biomarkers Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries in 2017
Figure Saudi Arabia Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure UAE Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Egypt Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure Nigeria Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Figure South Africa Neurological Biomarkers Revenue and Growth Rate (2013-2018)
Table Global Neurological Biomarkers Revenue (Million USD) by Type (2013-2018)
Table Global Neurological Biomarkers Revenue Share by Type (2013-2018)
Figure Global Neurological Biomarkers Revenue Share by Type (2013-2018)
Figure Global Neurological Biomarkers Revenue Share by Type in 2017
Table Global Neurological Biomarkers Revenue Forecast by Type (2018-2023)
Figure Global Neurological Biomarkers Market Share Forecast by Type (2018-2023)
Figure Global Genomics Biomarker Revenue Growth Rate (2013-2018)
Figure Global Proteomics Biomarker Revenue Growth Rate (2013-2018)
Figure Global Metabolomics Biomarkers Revenue Growth Rate (2013-2018)
Figure Global Imaging Biomarkers Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Neurological Biomarkers Revenue by Application (2013-2018)
Table Global Neurological Biomarkers Revenue Share by Application (2013-2018)
Figure Global Neurological Biomarkers Revenue Share by Application (2013-2018)
Figure Global Neurological Biomarkers Revenue Share by Application in 2017
Table Global Neurological Biomarkers Revenue Forecast by Application (2018-2023)
Figure Global Neurological Biomarkers Market Share Forecast by Application (2018-2023)
Figure Global Research Organizations, Pharma & Biotech Companies Revenue Growth Rate (2013-2018)
Figure Global Clinical Diagnostics Revenue Growth Rate (2013-2018)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Neurological Biomarkers Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Neurological Biomarkers Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Neurological Biomarkers Revenue Market Forecast (2018-2023)
Figure Europe Neurological Biomarkers Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Forecast (2018-2023)
Figure South America Neurological Biomarkers Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Neurological Biomarkers Revenue Market Forecast (2018-2023)
